跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
欧唐静 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Empagliflozin Tablets
Approved
化学药品
Empagliflozin Tablets
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Dec 20, 2021
Approval ID
8DqcE5ZzcDA
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8DqcE5ZzcDA
Approval Number
国药准字HJ20170351
Generic Name
恩格列净片
Generic Name En
Empagliflozin Tablets
Trade Name
欧唐静
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg
Reg Date
2021-12-20
Expired Date
2026-12-19
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 20, 2021
Approval ID
8DqcE5ZzcDA
Type
化学药品
Back to NMPA Approvals